ContraFect Corp (CFRX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: CFRX Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
2019-12-16	2019-12-13	B Purchase	Sucoff Cary Non-Executive Director	50,000 +416.7% 0.39 19,500 USD	50,000 +416.7%	0.39	19,500 USD
2019-12-16	2019-12-13	B Purchase	Low David N. Non-Executive Director	300,000 +425.2% 0.43 129,000 USD	300,000 +425.2%	0.43	129,000 USD
2019-12-16	2019-12-13	B Purchase	Messinger Michael Chief Financial Officer Officer	5,000 +35.5% 0.37 1,850 USD	5,000 +35.5%	0.37	1,850 USD
2018-12-06	2018-12-04	S Sale	Fosun Industrial Co., Ltd Large shareholder	600,000 -7.1% 2.04 1,224,000 USD	600,000 -7.1%	2.04	1,224,000 USD
2018-12-06	2018-12-04	S Sale	Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Large shareholder	600,000 -7.1% 2.04 1,224,000 USD	600,000 -7.1%	2.04	1,224,000 USD
2017-07-27	2017-07-25	B Purchase	BLECH ISAAC Non-Executive Director	16,000 +inf% 1.24 19,840 USD	16,000 +inf%	1.24	19,840 USD
2017-07-26	2017-07-25	B Purchase	Ricciardi Lisa Non-Executive Director	9,600 +inf% 1.24 11,904 USD	9,600 +inf%	1.24	11,904 USD
2017-07-26	2017-07-25	B Purchase	Sucoff Cary Non-Executive Director	12,000 +inf% 1.24 14,880 USD	12,000 +inf%	1.24	14,880 USD
2017-07-26	2017-07-25	B Purchase	Cassino Cara M Chief Medical Officer Officer	8,000 +inf% 1.24 9,920 USD	8,000 +inf%	1.24	9,920 USD
2017-07-26	2017-07-25	B Purchase	Low David N. Non-Executive Director	40,000 +130.9% 1.24 49,600 USD	40,000 +130.9%	1.24	49,600 USD
2017-07-26	2017-07-25	B Purchase	Bogdanos Natalie General Counsel Officer	800 +inf% 1.24 992 USD	800 +inf%	1.24	992 USD
2017-07-26	2017-07-25	B Purchase	BARER SOL J Non-Executive Director	40,000 +5.2% 1.24 49,600 USD	40,000 +5.2%	1.24	49,600 USD
2017-07-26	2017-07-25	B Purchase	Messinger Michael SVP Finance Officer	800 +6.0% 1.24 992 USD	800 +6.0%	1.24	992 USD
2017-07-26	2017-07-25	B Purchase	GILMAN STEVEN C CEO Executive Director	800 +4.0% 1.24 992 USD	800 +4.0%	1.24	992 USD
2017-07-26	2017-07-25	B Purchase	Pomerantz Roger Non-Executive Director	800 +inf% 1.24 992 USD	800 +inf%	1.24	992 USD
2017-07-26	2017-07-25	B Purchase	OTTO MICHAEL J. Non-Executive Director	8,000 +inf% 1.24 9,920 USD	8,000 +inf%	1.24	9,920 USD
2017-07-26	2017-07-25	B Purchase	Muntner Joshua B SVP Business Development Officer	2,000 +inf% 1.24 2,480 USD	2,000 +inf%	1.24	2,480 USD
2016-07-27	2016-07-27	B Purchase	GILMAN STEVEN C CEO Executive Director	20,000 +inf% 2.48 49,600 USD	20,000 +inf%	2.48	49,600 USD